Figure 1.
The pan-PIM inhibitor INCB053914 inhibits viable MPN model cell numbers in a concentration-dependent manner. (A) UKE1, SET2, and BaF3-JAK2VF cells were incubated with the indicated range of concentrations of INCB053914 (A) and ruxolitinib (B), and relative viable cells were determined after 72 hours (UKE1 and SET2) or 48 hours (BaF3-JAK2VF) by using CellTiter-Glo. Relative viable cell numbers are plotted as a percent of maximum for each drug concentration. Representative concentration-response curves are shown, and the average GI50’s of INCB053914 and ruxolitinib in each drug in each cell line are shown to the right of each graph.

The pan-PIM inhibitor INCB053914 inhibits viable MPN model cell numbers in a concentration-dependent manner. (A) UKE1, SET2, and BaF3-JAK2VF cells were incubated with the indicated range of concentrations of INCB053914 (A) and ruxolitinib (B), and relative viable cells were determined after 72 hours (UKE1 and SET2) or 48 hours (BaF3-JAK2VF) by using CellTiter-Glo. Relative viable cell numbers are plotted as a percent of maximum for each drug concentration. Representative concentration-response curves are shown, and the average GI50’s of INCB053914 and ruxolitinib in each drug in each cell line are shown to the right of each graph.

Close Modal

or Create an Account

Close Modal
Close Modal